Good point Kelt. I agree with that mostly but the gap between the current valuation and the target valuation if the drugs work is so vast that I think a lot of people see little incentive to take on the risk now when they can come in after good news and reduce their gains by a little and reduce their risk by a lot. If we all think the stock is going to say $25 (or $100) why not wait until good news and get in at 2 or 3 bucks. They still make a killing and the risk is vastly reduced. I'm not pretending i know that's how it would play out but I think there are a lot of investors who are far more risk averse than us. I don't think it's a matter of on or off the rocket. I think it's more of a matter of when you get on. I think the "smart" money is still on the sidelines and will remain there until the news is out. That's why my money is in now.